To ask the Scottish Executive what assessment it has made of the calls made by the Prostate Cancer Charter for Action, as relaunched in October 2005.
The current position inresponse to Prostate Cancer Charter for Action’s four priorities is as follows:
Resources
Cancer in Scotland: Action for change waspublished in 2001 backed by a significant new recurring investment of £25million. This money is for all cancer services and benefits all people withcancer of any type. Over £700,000 was targeted at prostate/urological cancersthrough the provision of a biopsy service, equipment such as ultrasoundscanners and cystoscopes, specialist nurses, staff for brachytherapy services andaudit staff for quality assurance of services.
Patient Care
NHS Quality ImprovementScotland is responsible for settingstandards for clinical care, assessing performance throughout NHSScotlandagainst these standards, and publishing the findings. As far as cancer is concerned NHS QIS has recentlyset up a steering group to review and revise existing standards, identify coreelements of cancer services and look at the possible development of new tumourspecific cancer standards.
A report on prostate cancer serviceswas prepared in 2002 setting out options for the future management of prostatecancer. Regional Cancer Advisory Groups and NHS Chief Executives were askedto consider this report when looking at options for the future management ofprostate cancer. Tumour specific multi-disciplinary teams, including those forurological cancers, are now in place across Scotland.
Transparency
There is a national data setfor prostate cancer in Scotland and data is routinely collected in most places. Urologicalcancer waiting times and detailed information on all aspects of Scotland’scancer strategy are available from the Scottish Executive website at:
www.scotland.gov.uk/Topics/Health/health/cancer/intro.Public Awareness
the Scottish Executive is represented on the Department of Health’s Prostate Cancer Advisory Group and will reviewthe results from the evaluation of their pilot campaign to raise awareness of the prostate and its function once these are available.